Effects of antipsychotic drugs on dopamine and serotonin contents and metabolites, dopamine and serotonin transporters, and serotonin(1A) receptors

Journal of Neural Transmission

Volumn 106, Issue 1, 1999, Pages 75-105

  Ase, A R ^a   Amdiss, F ^a   Hebert C ^a   Huang, N ^b   Van Gelder, N M ^c   Reader, T A ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

3,4 Dihydroxyphenylacetic acid; 3 Methoxytyramine; 5 Hydroxyindole 3 acetic acid; 5 Hydroxytryptophol; 8 Hydroxydipropylaminotetralin; Citalopram; Clozapine; Haloperidol; Homovanillic acid; RTI 121

Indexed keywords

CITALOPRAM; CLOZAPINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; HALOPERIDOL; NEUROLEPTIC AGENT; NEUROTRANSMITTER; PSYCHOTROPIC AGENT; SEROTONIN; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SODIUM CHLORIDE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CINGULATE GYRUS; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DORSAL RAPHE NUCLEUS; DOWN REGULATION; DRUG TOLERANCE; ENTORHINAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; INSULA; LONG TERM CARE; MALE; METABOLITE; NEOSTRIATUM; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; TISSUE LEVEL;

ANIMALS; ANTIPSYCHOTIC AGENTS; AUTORADIOGRAPHY; CARRIER PROTEINS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 0033014537     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050142     Document Type: Article

References (103)

1. Amara SG, Kuhar MJ (1993) Neurotransmitter transporters: recent progress. Ann Rev Neurosci 16: 73-93
2. Andén NE (1972) Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and anti-acetylcholine drugs. J Pharm Pharmacol 24: 905
3. Audet MA, Descarries L, Doucet G (1989) Quantified regional and laminar distribution of serotonin innervation in the anterior half of adult cerebral cortex. J Chem Neuroanat 2: 29-44
4. Barlow RB (1983) Biodata handling with microcomputers. Elsevier Science, Amsterdam
5. Bartolini G (1976) Differential effect of APD drugs on dopamine turnover in the extrapyramidal and limbic system. J Pharm Pharmacol 28: 429-433
6. Beckmann H, Jakob H (1991) Prenatal disturbances of nerve cell migration in the entorhinal region: a common vulnerability factor in functional psychosis? J Neural Transm (Gen Sect) 84: 155-164
7. 3 receptors in rat striatum. J Pharmacol Exp Ther 251: 803-809
8. Bobillier P, Séguin S, Degueurce A, Lewis BD, Pujol J-F (1979) The efferent connections of the nucleus raphe centralis superior in the rat as revealed by radioautography. Brain Res 166: 1-8
9. 125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12: 27-36
10. 125I]iodophenyl)tropane-2β-carboxylic acid isopropyl ester. Mol Pharmacol 47: 779-786
11. Bowers MBJr, Hoffman FJJr (1986) Homovanilic acid in caudate and pre-frontal cortex following acute and chronic neuroleptic administration. Psychopharmacology 88: 63-65
12. Brown E, Damsma G, Cumming P, Fibiger HC (1991) Interstitial 3-methoxytyramine reflects striatal dopamine release: an in vivo microdialysis study. J Neurochem 57: 701-707
13. Brunello N, Masotto C, Steardo L, Markstein R, Racagni G (1995) New insights into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacology 13: 177-213
14. Brusco A, Peressini S, Pecci-Saavedra J (1983) Serotonin-like immunoreactivity and anti-5-hydroxytryptamine (5-HT) antibodies: ultrastructural application in the central nervous system. J Histochem Cytochem 31: 524-530
15. 2A receptor mRNA and binding site densities are differentially altered in schizophrenia. Neuropharmacology 15: 442-455
16. Burnet PWJ, Chen CPLH, McGowan M, Franklin M, Harrison PJ (1996b) The effect of clozapine and haloperidol on serotonin-1A, serotonin-2A and serotonin-2C receptor gene expression and serotonin metabolism in the rat forebrain. Neuroscience 73: 531-540
17. 1C sites. Eur J Pharmacol 191: 93-96
18. Carli M, Morissette M, Hébert C, Di Paolo T, Reader TA (1997) Effects of a chronic lithium treatment on central dopamine neurotransporters. Biochem Pharmacol 54: 391-397
19. Carlsson A, Lindqvist M (1976) Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20: 140-144
20. Casey DE (1994) Extrapyramidal syndromes: primate models as predictors of clinical response. Neuropsychopharmacoiogy 10: 370S
21. Chang W-H, Jaw S-S, Tsay L (1989) Chronic haloperidol treatment with low doses may enhance the increase of homovanilic acid in rat brain. Eur J Pharmacol 162: 151-156
22. Chouinard G, Vainer JL, Bélanger M-C, Turnier L, Beaudry P, Roy J-Y, Milner R (1994) Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis. Progr Neuropsychopharmacol Biol Psychiatry 18: 1129-1141
23. Claghorn J, Honigfeld G, Abuzzahab FSSr, Wang R, Steinbrook R, Tuasou U, Klerman G (1987) The risks and benefits of clozapine versus chlorpromazine. J Clin Psychopharmacol 7: 377-384
24. Commissiong JW (1985) Monoamines metabolites: their relationship and lack of relationship to monoaminergic activity. Biochem Pharmacol 34: 1127-1131
25. Coward DM (1992) General pharmacology of clozapine. Br J Psychiatry [Suppl] 17: 5-11
26. Coward DM, Imperato A, Urwyler S, White TG (1989) Biochemical and behavioral properties of clozapine. Psychopharmacology [Suppl] 99: S6-S12
27. Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192: 481-483
28. 3H]GBR 12935 binding to dopamine uptake sites in postmortem brain tissue in schizophrenia. J Neural Transm 77: 227-230
29. Dean B, Hayes W (1996) Decreased frontal cortical serotonin 2A receptors in schizophrenia. Schizophr Res 21: 133-139
30. Deakin JT, Slater P, Simpson MD, Gilchrist AC, Skan WJ, Royston MC, Reynolds GP, Gross AJ (1989) Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J Neurochem 52: 1781-1786
31. 3H]-imipramine binding may predict psychiatric illness. Life Sci 44: 1403-1410
32. Descarries L, Watkins KC, Garcia S, Beaudet A (1982) The serotonin neurons in nucleus raphe dorsalis of adult rat: a light and electron microscope radioautographic study. J Comp Neurol 207: 239-254
33. 3H-paroxetine-labeled serotonin uptake sites in rat brain. Synapse 1: 488-496
34. 3H]Paroxetine binding and serotonin contents in rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region. Synapse 9: 14-26
35. Egan MF, Karoum F, Wyatt RJ (1991) Effects of acute and chronic clozapine and haloperidol on 3-methoxytyramine accumulation in rat prefrontal cortex, nucleus accumbens, and striatum. Eur J Pharmacol 199: 191-199
36. Eichenberger E (1984) Pharmacology of fluperlapine compared with clozapine. Drug Res 34: 110-113
37. Essig EC, Kilpatrick IC (1991) Influence of acute and chronic haloperidol treatment on dopamine metabolism in the rat caudate-putamen, prefrontal cortex and amygdala. Psychopharmacology 104: 194-200
38. Fallon JH, Loughlin SE (1982) Monoamine innervation of the forebrain: collateralization. Brain Res Bull 9: 295-307
39. Finlay JM, Jakubovic A, Fu DS, Fibiger HC (1987) Tolerance to haloperidol-induce increases in dopamine metabolites: fact or artefact? Eur J Pharmacol 137: 117-121
40. Frank H, Althoen SC (1994) Statistics: concepts and applications. Cambridge University Press, New York
41. Habeland N, Hetey L (1987) Studies in post mortem dopamine uptake. II. Alteration of the synaptosomal catecholamine uptake in post mortem brain region in schizophrenia. J Neural Transm 68: 303-313
42. Harandi M, Aguera M, Gamrani H, Didier M, Maiter M, Calas A, Belin MF (1987) Gamma-aminobutyric acid and 5-hydroxytryptamine interrelationship in the rat nucleus raphe dorsalis: combination of radioautographic and immunohistochemical techniques at light and electron microscopy levels. Neuroscience 21: 237-251
43. 2A receptor gene. Lancet 347: 1274
44. Hashimoto T, Nishino N, Nakai H, Tanaka C (1991) Increase in 5HT1A receptors in prefrontal and temporal cortices of brains from patients with schizophrenia. Life Sci 48: 355-363
45. 3H]imipramine localization and relationship to serotonin transporter. J Pharmacol Exp Ther 252: 410-418
46. 2 receptors: homogenate binding and autoradiographic studies. Neurochem Int 30: 277-290
47. Hyttel J (1982) Citalopram; basic and clinical studies. Progr Neuropsychopharmacol Biol Psychiatry 6: 275-336
48. Imperato A, Angelucci L (1988) Effects of the atypical neuroleptics clozapine and fluoperlapine on the in vivo dopamine release in the dorsal striatum and prefrontal cortex. Psychopharmacology 45: 780-789
49. Jakob H, Beckmann H (1994) Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenics. Pathogenetic and clinical aspects. J Neural Transm (Gen Sect) 98: 83-106
50. Joyce J, Shane A, Lexov N, Winokur A, Casanova MF (1993) Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 8: 315-336
51. Kahn RS, Davidson M (1993) Serotonin, dopamine and their interactions in schizophrenia. Psychopharmacology 112: S1-S4
52. Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic: a doble blind comparation with chlorpromazine. Arch Gen Psychiatry 45: 789-796
53. Kapur S, Remington G (1996) Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 153: 466-476
54. Karoum F, Egan MF (1992) Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparation of acute clozapine and haloperidol. Br J Pharmacol 105: 703-707
55. Kuczenski R, Leith NJ, Applegate CD (1983) Striatal dopamine metabolism in response to apomorphine: the effects of repeated amphetamine pretreatment. Brain Res 258: 333-337
56. Kuhar MJ, Sanchez-Roa PM, Wong DF, Dannals RF, Grigoriadis DE, Lew R, Milberger M (1990) Dopamine transporter: biochemistry, pharmacology and imaging. Eur Neurol 30 [Suppl]: 15-20
57. Kurashi M, Shibata R, Murata M, Tanii Y (1995) Parallel development of dopamine metabolism tolerance in the rat prefrontal cortex, caudate-putamen, and amygdala following haloperidol decanoate administration. Biol Psychiatry 37: 487-490
58. Laduron P, De Bie K, Leysen J (1977) Specific effect of haloperidol on dopamine turnover in the frontal cortex. Naunyn Schmiedebergs Arch Pharmacol 296: 183-185
59. Lakhdar-Ghazal N, Grondin L, Bengelloun WA, Reader TA (1986) Alpha-adrenoceptors and monoamine contents in the cerebral cortex of the rodent Jaculus orientalis: effects of acute cold exposure. Pharmacol Biochem Behav 25: 903-911
60. 3H]paroxetine binding, a marker of serotonin uptake sites. Biol Psychiatry 24: 299-309
61. Lieberman J, Lesser M, Johns C, Pollack S, Saltz B, Kane J (1988) Pharmacologic studies of tardive dyskinesia. J Clin Psychopharmacol 84 [Suppl 4]: 57S-63S
62. Lindvall O, Bjöklund A (1984) General organization of cortical monoamine systems. In: Descarries L, Reader TA, Jasper HH (eds) Monoamine innervation of cerebral cortex. Alan R Liss, New York, pp 9-40
63. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurements with the Folin phenol reagent. J Biol Chem 193: 265-275
64. 1 sites in the rat brain. Brain Res 291: 159-163
65. Matsumoto T, Uchimura H, Hirano M et al (1983) Differential effects of acute and chronic administration of haloperidol on homovanilic acid levels in discrete dopaminergic areas of rat brain. Eur J Pharmacol 89: 27-33
66. Mefford IN, Roth KA, Agren H, Barchas JD (1988) Enhancement of dopamine metabolism in rat brain frontal cortex: a common effect of chronically administered antipsychotic drugs. Brain Res 475: 380-384
67. 2, pKi values. J Pharmacol Exp Ther 251: 238-246
68. Moleman P, Bruinvels J, Van Valkenburg CFM (1978) Haloperidol inhibits the disappearence of acidic metabolites from the rat striatum. J Pharm Pharmacol 30: 583-585
69. Moore RY, Bloom FE (1978) Central catecholamine neuron systems: anatomy and physiology of the dopamine systems. Ann Rev Neurosci 1: 129-169
70. Mosko SS, Haubrich D, Jacobs BL (1977) Serotonin afferents in the dorsal raphe nucleus. Evidence from HRP and synaptosomal uptake studies. Brain Res 119: 269-290
71. Murray AM, Waddington JL (1990) The interaction of clozapine with dopamine D1 versus D2 receptor-mediated function: behavioural indices. Eur J Pharmacol 186: 79-86
72. 3H]5-hydroxytryptamine. Neuroscience 6: 115-138
73. Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, Sydney
74. Pearce RK, Seeman P, Jellinger K, Tourtellotte WW (1990) Dopamine uptake site and dopamine receptors in Parkinson's disease and schizophrenia. Eur Neurol 1: 9-14
75. Pecci-Saavedra J, Brusco A, Peressini S, Oliva D (1986) A new case for presynaptic role of dendrites: an immunocytochemical study of the N. raphé dorsalis. Neurochem Res 11: 997-1009
76. 3H]citalopram binding to brain and platelet membranes of human and rat. J Neurochem 56: 248-252
77. Radja F, Laporte A-M, Daval G, Vergé D, Gozlan H, Hamon M (1991) Autoradiography of serotonin receptor subtypes in the central nervous system. Neurochem Int 18: 1-15
78. 2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: a quantitative autoradiographic study. Brain Res 606: 273-285
79. Raison S, Rousset C, Pujol J-F, Weissmann D (1996) p-Chlorophenylalanine-induced alteration of somatodendritic levels of tryptophan hydroxylase within the rat mesencephalic raphe nuclei. J Neurochem 67: 2124-2133
80. Reader TA, Grondin L (1987) Distribution of catecholamines, serotonin, and their major metabolites in the rat cingulate. piriform-entorhinal, somatosensory, and visual cortex: a biochemical survey using high-performance liquid chromatography. Neurochem Res 12: 1087-1097
81. Reader TA, Dewar KM, Grondin L (1989) Distribution of monoamines and metabolites in rabbit neostriatum, hippocampus and cortex. Brain Res Bull 23: 237-247
82. Reader TA, Radja F, Dewar KM, Descarries L (1995) Denervation, hyperinnervation and interactive regulation of dopamine and serotonin receptors. Ann NY Acad Sci 757: 293-310
83. Reader TA, Ase AR, Huang N, Hébert C, van Gelder NM (1998) Neuroleptics and dopamine transporters. Neurochem Res 23: 73-80
84. Reynolds GP (1994) Antipsychotic drugs mechanisms and neurotransmitter system in schizophrenia. Acta Psychiatr Scand 380 [Suppl]: 36-40
85. Saller CF, Salama AI (1985) Alteration in dopamine metabolism after chronic administration of haloperidol. Neuropharmacology 24: 123-129
86. Sanger DJ (1985) The effects of clozapine on shuttle-box avoidance responding in rats: comparations with haloperidol and chlordiazepoxide. Pharmacol Biochem Behav 23: 231-236
87. Sauvé Y, Reader TA (1988) Effects of α-methyl-p-tyrosine on monoamines and catecholamine receptors in rat cerebral cortex and neostriatum. Neurochem Res 13: 807-815
88. Scatton BJ (1977) Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration. Eur J Pharmacol 46: 363-369
89. Scatton BJ, Glowinski J, Julou L (1976) Dopamine metabolism in the mesolimbic and mesocortical dopaminergic systems after single or repeated administration of neuroleptics. Brain Res 109: 184-189
90. Seeman P (1987) Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1: 133-152
91. Seeman P, Lee T, Chau-Wong M, Wong K (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261: 717-721
92. 125I]RTI-121. Synapse 21: 364-372
93. Steinbusch HWM (1981) Distribution of serotonin-immunoreactivity in the central nervous system of the rat - cell bodies and terminals. Neuroscience 6: 557-618
94. 3H]citalopram quantitative autoradiography. J Chem Neuroanat 10: 157-171
95. 125I]RTI-121 quantitative autoradiography. Neurochem Int 32: 61-68
96. Van Rossum JM (1966) The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Arch Int Pharmacodyn Ther 160: 492-494
97. 1 receptor subtypes in the brain of control of 5,7-dihydroxytryptamine-treated rats. J Neurosci 12: 3474-3482
98. Waldmeier PC, Maître L (1976) Clozapine: Reduction of the initial dopamine turnover increase by repeated treatment. Eur J Pharmacol 38: 197-203
99. Westerink BHC, Korf J (1976) Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanilic acid: concurrent fluorometric measurements and influence of drugs. Eur J Pharmacol 38: 281-291
100. Westerink BHC, Lejeune B, Korf J, Van Praag HM (1977) On the significant of regional dopamine metabolism in the rat brain for the clasification of centrally acting drugs. Eur J Pharmacol 23: 104
101. Westerink BHC, Bosker FJ, Wirix E (1984) Formation and metabolism of dopamine in nine areas of the rat brain: modification by haloperidol. J Neurochem 42: 1321-1327
102. White FJ, Wang RY (1983) Differential effect of classical and atypical antypsychotic drugs on A9 and A10 dopamine neurons. Science 221: 1054-1055
103. Wood PL, Altar CA (1988) Dopamine release in vivo from nigrostriatal, mesolimbic, and mesocortical neurons: utility of 3-methoxytyramine measurements. Pharmacol Rev 40: 164-187